TRPA1 expression is downregulated by dexamethasone and aurothiomalate in human chondrocytes: TRPA1 as a novel factor and drug target in arthritis
Saved in:
Main Authors: | Eeva Moilanen, Katriina Vuolteenaho, Teemu Moilanen, Elina Nummenmaa, Mari Hämäläinen, Lauri J Moilanen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2017-09-01
|
Series: | RMD Open |
Online Access: | https://rmdopen.bmj.com/content/3/2/e000556.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
YKL-40 as a Novel Factor Associated with Inflammation and Catabolic Mechanisms in Osteoarthritic Joints
by: Tuija Väänänen, et al.
Published: (2014-01-01) -
Leptin Enhances Synthesis of Proinflammatory Mediators in Human Osteoarthritic Cartilage—Mediator Role of NO in Leptin-Induced PGE2, IL-6, and IL-8 Production
by: Katriina Vuolteenaho, et al.
Published: (2009-01-01) -
A Novel Model of Cancer-Induced Peripheral Neuropathy and the Role of TRPA1 in Pain Transduction
by: Ahmad Maqboul, et al.
Published: (2017-01-01) -
Down-Regulation of Tristetraprolin Expression Results in Enhanced IL-12 and MIP-2 Production and Reduced MIP-3α Synthesis in Activated Macrophages
by: Ulla Jalonen, et al.
Published: (2006-01-01) -
Optimization and calibration of 384-well kinetic Ca2+ mobilization assays for the human transient receptor potential cation channels TRPM8, TRPV1, and TRPA1
by: David A. Close, et al.
Published: (2025-01-01)